See more : Merkur PrivatBank KgaA (MBK.DE) Income Statement Analysis – Financial Results
Complete financial analysis of Capha Pharmaceuticals Inc. (FPSUF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Capha Pharmaceuticals Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Cosa Resources Corp. (COSA.CN) Income Statement Analysis – Financial Results
- Transition Metals Corp. (TNTMF) Income Statement Analysis – Financial Results
- iAnthus Capital Holdings, Inc. (ITHUF) Income Statement Analysis – Financial Results
- two (TWOA) Income Statement Analysis – Financial Results
- The Williams Companies, Inc. (WMB.DE) Income Statement Analysis – Financial Results
Capha Pharmaceuticals Inc. (FPSUF)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
About Capha Pharmaceuticals Inc.
Capha Pharmaceuticals Inc. does not have significant operations. It intends to explore opportunities in the pharmaceutical distribution business. The company was formerly known as FPS Pharma Inc. and changed its name to Capha Pharmaceuticals Inc. in January 2017. Capha Pharmaceuticals Inc. was incorporated in 2004 and is based in West Kelowna, Canada.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 141.51 | 209.70 | 310.27 | 482.37 | 683.55 |
| Gross Profit | -141.51 | -209.70 | -310.27 | -482.37 | -683.55 |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 25.90K | 29.32K | 29.20K | 67.37K | 0.00 |
| Selling & Marketing | 27.10K | 28.36K | 15.30K | -17.14K | 0.00 |
| SG&A | 53.00K | 57.68K | 44.49K | 50.23K | 64.71K |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 53.00K | 57.68K | 44.49K | 50.23K | 64.71K |
| Cost & Expenses | 53.14K | 57.89K | 44.80K | 50.71K | 65.39K |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 141.51 | 209.70 | 310.27 | 482.37 | 683.55 |
| EBITDA | -53.22K | -57.68K | -44.49K | -50.23K | -64.61K |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -53.14K | -57.89K | -44.80K | -50.71K | -65.39K |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -222.00 | -414.00 | -5.00 | -450.00 | 101.00 |
| Income Before Tax | -53.36K | -58.31K | -44.81K | -51.16K | -65.29K |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | -1.52 | 7.94 | -0.27 | -2.34 | -4.41 |
| Net Income | -53.36K | -58.31K | -44.81K | -51.16K | -65.29K |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Weighted Avg Shares Out | 64.48M | 64.43M | 64.43M | 64.43M | 64.43M |
| Weighted Avg Shares Out (Dil) | 64.43M | 64.43M | 64.43M | 64.43M | 64.43M |
Source: https://incomestatements.info
Category: Stock Reports